Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Total Current Liabilities (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Total Current Liabilities for 10 consecutive years, with $46.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 36.03% to $46.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.2 million, a 36.03% increase, with the full-year FY2025 number at $46.2 million, up 36.03% from a year prior.
  • Total Current Liabilities was $46.2 million for Q4 2025 at Orthopediatrics, up from $33.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $47.9 million in Q3 2023 to a low of $28.0 million in Q3 2021.
  • A 5-year average of $36.4 million and a median of $34.9 million in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 164.77% in 2021, then decreased 27.75% in 2024.
  • Orthopediatrics' Total Current Liabilities stood at $29.7 million in 2021, then rose by 3.89% to $30.9 million in 2022, then skyrocketed by 34.97% to $41.7 million in 2023, then fell by 18.49% to $34.0 million in 2024, then surged by 36.03% to $46.2 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Total Current Liabilities are $46.2 million (Q4 2025), $33.2 million (Q3 2025), and $38.7 million (Q2 2025).